• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Adverse Events (non-infectious)

Alloimmunization to One RBC Antigen Triggers Alloimmunization to Other RBC Antigens

The risk of alloimmunization to polymorphic RBC antigens is high for individuals who undergo chronic transfusion therapy.  Researchers recently utilized…

January 31, 2018

Restrictive Transfusions Threshold Safe for Cardiac Surgery Patients

While a restrictive transfusion strategy has been advocated for most patients, a restrictive approach for cardiac surgery patients may put…

November 22, 2017

Genetic Variation in the Fc-gamma Receptor Gene is Associated with Protection against RBC Alloimmunization

 Genetic variation in the Fc-ɣ receptor gene has been shown to be associated with some auto- and alloimmune diseases. Researchers…

November 16, 2017

Trying to Decipher Relationship between Previously Pregnant Donors and RBC Transfusion-related Mortality

Although blood from previously pregnant female donors has been shown to be associated with transfusion-related acute lung injury (TRALI), the…

October 25, 2017

Bedside Checklists Could Prevent Most ABO-Incompatible Transfusions and Other Adverse Events

Since 1996, the hemovigilance surveillance system in the United Kingdom has collected and published yearly reports on the serious hazards…

August 16, 2017

Patients with Hematologic Cancers Have Lower Rates of Alloimmunization with RhD

Over 20% of RhD-negative non-oncology patients exposed to RhD-positive red blood cells (RBCs) become alloimmunized to the RhD antigen. In…

February 22, 2017

KEL-Antigen Modulation is Important for Anti-KEL Immunoprophylaxis

Rh immunoglobulin therapy has been used for more than 60 years to prevent alloimmunization in Rh-negative pregnant women carrying an…

January 5, 2017

Eculizumab Treatment May Be Beneficial For Treating Hemolysis Transfusion Reactions in Patients with Sickle Cell Disease

Delayed hemolytic transfusion reactions (DHTR) in patients with sickle cell disease can lead to multiple organ failure and may be…

March 2, 2016

Chronic Lymphocytic Leukemia is not Transmitted through Transfusions

Monoclonal B-cell lymphocytosis (MBL), a precursor of chronic lymphocytic leukemia (CLL), can be present in healthy blood donors. This raises…

November 6, 2015

FDA Reports Safest Blood Supply in History

In the Fatalities Reported to the FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2014, the FDA…

September 11, 2015

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Go to Next Page »

Primary Sidebar

Latest News

  • Recombinant ADAMTS13 for Treatment of Congenital Thrombotic Thrombocytopenic Purpura

  • Peripheral Blood Stem Cell Collection Versus Bone Marrow Harvest for Individuals with Sickle Cell Trait

  • Oral Mitapivat to Treat Transfusion-Dependent Thalassemia

  • Increased Mortality in Trauma Patients with Non-identical ABO Transfusions

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley